Nexaph peptides represent a novel clinical strategy targeting disease progression. These specially designed entities leverage the unique properties of short peptide sequences to modulate cellular activities involved in inflammation, fibrosis, and tumor development. Research demonstrate their capability for addressing a spectrum of long-term disease